M
Maicon Falavigna
Researcher at Universidade Federal do Rio Grande do Sul
Publications - 108
Citations - 6354
Maicon Falavigna is an academic researcher from Universidade Federal do Rio Grande do Sul. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 27, co-authored 89 publications receiving 4227 citations. Previous affiliations of Maicon Falavigna include McMaster University & Pontifícia Universidade Católica do Rio Grande do Sul.
Papers
More filters
Journal ArticleDOI
EE554 Costs Comparison Between Dupilumab and Omalizumab in the Treatment of Severe Allergic Asthma in the Brazilian Private Healthcare Perspective
A Barbosa,Fjb Magro,A. Taminato,PG Federico,Rnt Prioli,Suely Goldflus,CB Migliavaca,Maicon Falavigna +7 more
TL;DR: In this paper , the authors compare the treatment costs of dupilumab and omalizumab for severe allergic asthma patients in the Brazilian private healthcare perspective, and show that dupiluma is more effective in treating severe allergic patients.
Journal ArticleDOI
CO82 Dupilumab Is Effective in Patients with Atopic Dermatitis and Inadequate Response, Intolerance, or Contraindication to Cyclosporine: A Systematic Review and Meta-Analysis
Frederico José Bighetti Magro,CB Migliavaca,Daniela Gräf,N. Schneider,Maicon Falavigna,Fabiana ZS Bosnich,A Barbosa,PG Federico,A. Taminato,Patricia Guyot +9 more
Journal ArticleDOI
Risk factors for hyperactive delirium among icu adult patients in southern brazil: a prospective cohort study.
RPd Oliveira,R Rosa,A Ascoli,W Rutzen,L Madeira,P Balzano,P Morandi,Souto,F Vargas,L Lago,Camila Dietrich,J. C. Rezende,F Ghizzoni,Mps Souza,Cátia Moreira Guterres,Maicon Falavigna,Karine Margarites Lima,Caroline Cabral Robinson,R.D.X. Ribeiro,Juçara Gasparetto Maccari,Cassiano Teixeira +20 more
TL;DR: A large number of patients in the ICU are diagnosed with delirium, which is associated with worse outcomes among intensive care unit (ICU) patients, and the number of admissions is higher than in other intensive care units.
Posted ContentDOI
Pan-American Guidelines for the Treatment of SARS-CoV-2/COVID-19: A Joint Evidence-Based Guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API) (preprint)
Alexandre Naime Barbosa,Alberto Chebabo,Carlos Ernesto Ferreira Starling,Clevy Perez,Clovis Arns da Cunha,David de Luna,Estevão Portela Nunes,Juliana Carvalho Ferreira,Julio Croda,Maicon Falavigna,Mónica Silva,Monica Thormann,Sergio Cimerman,Suena Medeiros Parahiba,Suzana Erico Tanni,Wanderley Marques Bernardo,Alfonso J. Rodriguez-Morales +16 more
TL;DR: In this paper , the authors present a set of drugs that have proven effective in the prophylaxis and treatment of COVID-19, emphasising the strong recommendation for the use of nirmatrelvir/ritonavir in outpatients as the lack of benefit from using hydroxychloroquine and ivermectin.
Journal ArticleDOI
Association Between Dietary Fatty Acid Composition and Diabetes Kidney Disease: Systematic Review, Meta-analysis and Trial Sequential Analysis of Observational Studies
Cristina Pavinatto,Maicon Falavigna,Sandra Pinho Silveiro,Alice H. Lichtenstein,Themis Zelmanovitz +4 more
TL;DR: In patients with diabetes, saturated fatty acid (SFA) and polyunsaturated fatty acids (PUFA) has been reported to have negative and positive effects, respectively, on diabetes kidney disease (DKD) as discussed by the authors .